Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1778056
Max Phase: Preclinical
Molecular Formula: C39H72N2O14
Molecular Weight: 793.00
Molecule Type: Small molecule
Associated Items:
ID: ALA1778056
Max Phase: Preclinical
Molecular Formula: C39H72N2O14
Molecular Weight: 793.00
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)CC(=O)NC)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@]1(C)O
Standard InChI: InChI=1S/C39H72N2O14/c1-14-26-39(10,49)32(45)21(4)29(43)19(2)16-37(8,48)34(55-36-30(44)25(15-20(3)51-36)41(12)18-27(42)40-11)22(5)31(23(6)35(47)53-26)54-28-17-38(9,50-13)33(46)24(7)52-28/h19-26,28-34,36,43-46,48-49H,14-18H2,1-13H3,(H,40,42)/t19-,20-,21+,22+,23-,24+,25+,26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39-/m1/s1
Standard InChI Key: DJJVZZWADLZGBY-DDFPVJQSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 793.00 | Molecular Weight (Monoisotopic): 792.4984 | AlogP: 0.69 | #Rotatable Bonds: 9 |
Polar Surface Area: 226.17 | Molecular Species: NEUTRAL | HBA: 15 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.45 | CX Basic pKa: 7.57 | CX LogP: 0.81 | CX LogD: 0.42 |
Aromatic Rings: 0 | Heavy Atoms: 55 | QED Weighted: 0.16 | Np Likeness Score: 1.42 |
1. Liu Y, Carreras CW, Claypool M, Myles DC, Shaw SJ.. (2011) The role of the 4''-hydroxyl on motilin agonist potency in the 9-dihydroerythromycin series., 21 (12): [PMID:21570844] [10.1016/j.bmcl.2011.04.078] |
Source(1):